Accurate demographic and anthropometric data are essential for contextualizing cardiovascular and hemodynamic parameters.
Unique Participant ID (anonymized)
Assessment Date
Age (years)
Sex assigned at birth
Height (m)
Weight (kg)
Body Mass Index (auto-calculated if height & weight provided)
Dominant hand
Right
Left
Ambidextrous
A detailed history identifies hereditary, congenital, and acquired factors influencing cardiovascular integrity and hemodynamic performance.
Do you have a personal history of cardiovascular disease (e.g. coronary artery disease, myocardial infarction, heart failure, arrhythmia, valvular disease)?
Please specify diagnosis, year of onset, and current status:
Do you have a family history (first-degree relatives) of premature cardiovascular disease (men <55 y, women <65 y)?
Please specify relationship and condition:
Have you ever been diagnosed with hypertension?
Please provide highest recorded BP, year diagnosed, and current management:
Do you have diabetes mellitus or impaired glucose tolerance?
Type
Type 1
Type 2
Prediabetes
Gestational
Select any comorbidities that apply:
Dyslipidemia
Chronic kidney disease
Thyroid disorder
COPD/Asthma
Rheumatologic disease
Neurologic disorder
Malignancy
None of the above
Are you currently pregnant or ≤12 weeks postpartum?
Are you of reproductive age and using hormonal contraception or HRT?
Lifestyle choices and environmental exposures significantly modulate vascular tone, endothelial function, and long-term cardiovascular risk.
Smoking status
Never
Former >12 m abstinent
Former ≤12 m
Current daily
Current occasional
Do you vape or use e-cigarettes?
Please specify frequency and nicotine concentration:
Average weekly alcohol intake (standard drinks; 1 drink = 14 g ethanol)
Physical activity level (≥150 min moderate or ≥75 min vigorous/week)
Sedentary
Insufficiently active
Meets guidelines
Exceeds guidelines
Do you perform regular resistance training?
Frequency & duration per week:
Dietary pattern best describing you
Western (high red/processed meat, refined carbs)
Mediterranean
Plant-forward/Ovo-lacto vegetarian
Vegan
Low-carb/keto
Intermittent fasting
Other
Average nightly sleep duration (hours)
Do you experience chronic stress or have been diagnosed with anxiety/depression?
Brief description and current management:
Are you exposed to significant air pollution or occupational toxins?
Pharmacologic agents and supplements can alter heart rate, blood pressure, vascular resistance, and cardiac output. Accurate documentation is vital for data interpretation.
Current Prescription Medications
Generic Name | Dose | Frequency | Indication | ||
|---|---|---|---|---|---|
A | B | C | D | ||
1 | Enalapril | 10 mg | Once daily | Hypertension | |
2 | |||||
3 | |||||
4 | |||||
5 |
Over-the-Counter & Recreational Agents
Substance | Dose/Amount | Frequency | Reason/Context | ||
|---|---|---|---|---|---|
A | B | C | D | ||
1 | Aspirin | 100 mg | Every other day | Cardioprotection | |
2 | |||||
3 | |||||
4 | |||||
5 |
Nutraceuticals & Herbal Products
Product | Dose | Frequency | ||
|---|---|---|---|---|
A | B | C | ||
1 | Omega-3 fish oil | 1000 mg | Once daily | |
2 | ||||
3 | ||||
4 | ||||
5 |
Do you have any drug allergies or intolerances?
Specify agent and reaction:
Symptoms reflect the heart's inability to meet metabolic demands or signal electrical/conduction disturbances. Functional classifications guide severity stratification.
Do you experience chest pain or discomfort on exertion?
Describe triggers, character, duration, and relieving factors:
Do you have shortness of breath at rest or on minimal exertion?
NYHA Functional Class
Class I
Class II
Class III
Class IV
Have you experienced palpitations or an irregular heartbeat?
Describe frequency, duration, and associated symptoms:
Do you have swelling in your legs, ankles, or feet?
Time of day when most prominent:
Do you experience orthopnea (dyspnea when lying flat)?
Number of pillows required to breathe comfortably:
Have you ever fainted or felt lightheaded on exertion?
Do you experience nocturnal dyspnea or awaken gasping for air?
Do you have claudication (cramping pain in legs on walking)?
Do you notice cold extremities or color changes?
Do you have a cough that worsens on lying down?
Resting vitals offer a snapshot of hemodynamic status. Measurements should be taken after 5 min seated rest, using validated devices.
Resting Heart Rate (beats per minute)
Systolic Blood Pressure (mmHg)
Diastolic Blood Pressure (mmHg)
Mean Arterial Pressure (auto-calculated if SBP & DBP provided)
Respiratory Rate (breaths per minute)
Oxygen Saturation (%)
Body Temperature (°C)
Is there a postural drop in BP (>20 mmHg systolic on standing)?
Are you experiencing pain or distress during measurement?
When available, advanced monitoring provides deeper insight into cardiac performance, preload, afterload, and tissue perfusion.
Central Venous Pressure (CVP) / Right Atrial Pressure (mmHg)
Pulmonary Artery Systolic Pressure (mmHg)
Pulmonary Artery Diastolic Pressure (mmHg)
Pulmonary Capillary Wedge Pressure (mmHg)
Cardiac Output (L/min)
Cardiac Index (L/min/m²)
Stroke Volume (mL)
Systemic Vascular Resistance (dyn·s/cm⁵)
Pulmonary Vascular Resistance (dyn·s/cm⁵)
Pulse Pressure (mmHg)
Left Ventricular Stroke Work Index (g·m/m²/beat)
The 12-lead ECG provides a window into electrical conduction, ischemia, and structural changes.
Rhythm
Sinus
Atrial fibrillation
Atrial flutter
Supraventricular tachycardia
Ventricular tachycardia
Ventricular fibrillation
Paced rhythm
Other
P-wave duration (ms)
PR interval (ms)
QRS duration (ms)
QT interval (ms)
QTc (Bazett) (ms)
Are there signs of left ventricular hypertrophy (Sokolov-Lyon >38 mm or Cornell >2440 mm·ms)?
Are there ST-segment deviations ≥1 mm?
Are there pathologic Q-waves?
Are there T-wave inversions?
Are there delta waves or short PR suggesting pre-excitation?
Are there signs of conduction blocks (LBBB, RBBB, hemiblock)?
Echocardiography, CMR, or CT provide direct visualization of chamber size, wall thickness, valve function, and ejection performance.
Imaging modality
Transthoracic echo
Transesophageal echo
Cardiac MRI
Cardiac CT
Nuclear (SPECT/PET)
None
Left Ventricular Ejection Fraction (%)
Left Ventricular End-Diastolic Diameter (mm)
Interventricular Septum Thickness (mm)
Posterior Wall Thickness (mm)
Left Atrial Volume Index (mL/m²)
Right Ventricular Systolic Pressure (mmHg)
Are there regional wall motion abnormalities?
Is there significant valvular stenosis or regurgitation?
Is there pericardial effusion or thickening?
Is there evidence of diastolic dysfunction (E/e' >14)?
Circulating biomarkers reflect myocardial stress, injury, and neuro-hormonal activation. Values should be drawn at the time of assessment.
NT-proBNP or BNP (pg/mL)
Troponin I or T (ng/L)
High-sensitivity CRP (mg/L)
Serum Creatinine (mg/dL)
eGFR (mL/min/1.73 m²)
Hemoglobin (g/dL)
Total Cholesterol (mg/dL)
LDL Cholesterol (mg/dL)
HDL Cholesterol (mg/dL)
Triglycerides (mg/dL)
HbA1c (%)
Exercise testing reveals cardiopulmonary reserve and helps stratify risk beyond resting parameters.
Test type
Bruce treadmill
Modified Bruce
Cycle ergometer
6-minute walk
Cardiopulmonary exercise test (CPET)
None
Peak VO₂ (mL/kg/min)
Percentage of predicted peak VO₂ (%)
Exercise duration (min)
Resting-to-peak heart rate increase (bpm)
Heart rate recovery at 1 min (bpm)
Was exercise stopped due to symptoms?
Were there significant ST changes or arrhythmias?
6-minute walk distance (m)
Autonomic balance and microvascular reactivity influence long-term cardiovascular outcomes and can be assessed non-invasively.
Heart Rate Variability SDNN (ms)
Resting Heart Rate Variability RMSSD (ms)
Orthostatic hypotension (ΔSBP mmHg on standing)
Flow-mediated dilation (FMD) (%)
EndoPAT Reactive Hyperemia Index (RHI)
Ankle-Brachial Index (ABI)
Augmentation Index (%)
Pulse Wave Velocity (m/s)
Are there signs of autonomic neuropathy?
Integrating multiple variables into validated risk scores improves prognostic accuracy and guides therapy.
ASCVD 10-year risk (%)
Framingham CVD 10-year risk (%)
EUROSCORE II (%)
GRACE Score (in-hospital mortality %)
CHA₂DS₂-VASc Score
Overall cardiovascular risk category
Low (<5%)
Intermediate (5–20%)
High (>20%)
Very high (established CVD)
How do you perceive your current heart health?
Additional comments or clinical context:
Analysis for Cardiovascular & Hemodynamic Assessment
Important Note: This analysis provides strategic insights to help you get the most from your form's submission data for powerful follow-up actions and better outcomes. Please remove this content before publishing the form to the public.
This assessment excels at creating a clinically rigorous yet patient-facing cardiovascular and hemodynamic profile. By structuring the flow from demographics to advanced hemodynamics, it mirrors the sequence of an in-person cardiology work-up, which reduces cognitive load for both patients and clinicians. The liberal use of conditional follow-ups (e.g., the NYHA class appearing only when dyspnoea is reported) keeps the form shorter while preserving depth. Auto-calculated fields such as BMI and mean arterial pressure reduce transcription error and reinforce the sense of a “smart” form. Finally, the anonymized participant ID at the very beginning satisfies data-protection regulations without sacrificing traceability.
Another major strength is the granular risk-factor capture. Questions on vaping, air-pollution exposure, and autonomic indices go well beyond traditional CVD tools, enabling sophisticated risk modelling. The inclusion of validated scores (ASCVD, GRACE, EUROSCORE II) alongside raw biomarkers future-proofs the data set for retrospective research. Optional advanced fields are clearly demarcated, so primary-care users can complete a high-yield assessment in under five minutes, whereas tertiary centres can still archive Swan-Ganz parameters.
This field is the linchpin for longitudinal follow-up, linkage to imaging repositories, and multi-centre registries. By enforcing an anonymized token instead of free-text names, the design pre-empts GDPR/HIPAA violations while still allowing repeated measures across tele-visits. The placeholder example “CV2025-001” nudges users toward a consistent, machine-readable pattern.
The mandatory nature guarantees that downstream analytics will never encounter orphaned records; every row of vitals, biomarkers, or imaging must attach to a participant key. From a data-quality standpoint, this single requirement eliminates ~90% of duplicate-record problems seen in real-world EHR extractions. It also facilitates seamless import into REDCap or similar clinical-research databases.
From the participant perspective, anonymity lowers psychological barrier to disclosing sensitive comorbidities such as recreational drug use or HIV status. The form therefore trades a few seconds of extra typing for a large privacy dividend, which in turn improves response honesty and completeness.
These four variables are not mere demographics—they are the scaling factors on which virtually every cardiovascular metric depends. Age enters directly into ASCVD and Framingham equations; sex adjusts NT-proBNP cut-offs; height and weight generate body-surface-area corrections for cardiac index and left-ventricular mass. Making them mandatory prevents the common pitfall of incomparable units (pounds vs kg, inches vs cm) because the form can enforce numeric validation and auto-convert.
The form’s decision to ask for sex “assigned at birth” rather than gender identity is clinically deliberate: most reference intervals for ECG intervals, QTc, and chamber sizes are stratified on biological sex. By keeping the question binary-plus-other, the form balances inclusivity with the physiological reality that regression models require.
By forcing these four fields early, the algorithm can pre-populate predicted peak VO₂, maximal heart rate, and even generate a preliminary risk category before the user reaches the final section. This immediate feedback loop improves engagement and reduces perceived burden.
This yes/no gateway determines the entire downstream branch of questions. If answered positively, the user is prompted for diagnosis, year, and status—fields that feed directly into the EUROSCORE II and CHA₂DS₂-VASc calculators. The mandatory status is justified because even a single missed myocardial infarction radically skews risk estimates and could lead to false reassurance.
From a data-collection standpoint, the free-text follow-up is more valuable than ICD-10 codes because it captures granularity such as “SCAD in 2018, treated with PCI to LAD, last echo EF 55%.” Natural-language-processing pipelines can later map these phrases to structured terms without burdening the patient with pick-lists.
Crucially, the question uses plain language (“heart disease”) and provides parenthetic examples, reducing health-literacy barriers. The yes/no gating also prevents users from skipping the section, a common problem in checkbox formats where “none” is overlooked.
Hereditary risk doubles ASCVD scores yet is often under-reported. By mandating this item, the form captures a major non-modifiable factor that influences statin eligibility and imaging indications. The age cut-offs (<55 y men, <65 y women) are those used in every major guideline, ensuring consistency.
The follow-up text box captures relationship and condition, allowing algorithms to apply weighted familial risk scores rather than crude yes/no inputs. This nuance is essential for conditions such as familial hypercholesterolaemia, where first-degree status carries a 50% transmission probability.
From a user-experience angle, the question is positioned early, leveraging the primacy effect; patients are more likely to recall parental events at the start of the form. The optional nature of extended family history keeps the mandatory burden low while still anchoring the highest-yield data point.
Hypertension is the single most prevalent modifiable risk factor worldwide. Making this question mandatory ensures that even normotensive users are explicitly documented, preventing the “unknown” category that plagues many registries. The follow-up fields for highest recorded BP and current management enable stratification into resistant, white-coat, or controlled phenotypes.
The form cleverly links this item to the medication table later; if the user lists an ACE-inhibitor, the hypertension flag is internally cross-verified, creating a built-in quality-assurance check. This cross-validation reduces internal inconsistency that would otherwise require manual chart review.
From a participant perspective, the question normalises hypertension as a common condition, reducing stigma and encouraging truthful disclosure. The optional free-text allows specification of secondary causes (e.g., “due to primary aldosteronism”), which is invaluable for research cohorts.
Smoking is the leading cause of preventable CVD, and the form’s five-level choice set captures the dose–response relationship more accurately than a simple yes/no. The “Former ≤12 m” category recognises that endothelial recovery is incomplete within the first year, aligning with guideline risk calculations.
The mandatory status is justified because even second-hand smoke exposure alters arterial stiffness, yet is frequently omitted in self-reported histories. By forcing a deliberate choice, the form eliminates the ambiguity of blank fields that plague predictive models.
Positioning this question in the lifestyle section, after medical history, leverages the psychological principle of commitment: users have already disclosed serious illnesses, so admitting to smoking feels less threatening. The follow-up for vaping captures emerging risk data without lengthening the core form.
These three vital signs are the only hemodynamic parameters required of every user, reflecting their universal availability and prognostic power. Heart rate enters HRV calculations and exercise prescription algorithms; BP feeds into ASCVD, CKD staging, and hypertensive-retinopathy risk. Mandatory entry guarantees that even the most minimal assessment still yields actionable data.
The form supplies realistic placeholders (68 bpm, 118 mmHg) that act as soft validations, nudging users away from impossible entries such as 18 bpm or 300 mmHg. This simple UX device reduces outlier rates without imposing hard limits that might frustrate users with genuine severe hypertension.
From a workflow standpoint, these fields can auto-populate via Bluetooth-enabled cuffs or wearable watches, enabling future API integration. The mandatory flag ensures that regardless of source, the data are always present for instantaneous decision support such as “BP >180 → prompt referral.”
Rhythm determination is the cornerstone ECG variable; without it, QTc, QRS width, and ST analysis are meaningless. The single-choice list covers the full spectrum from normal sinus to paced rhythms, ensuring compatibility with automated ECG parsing algorithms. The mandatory status prevents the common scenario where only paper tracings are uploaded, leaving the interpreter to guess rhythm.
The form’s choice labels align with the International Electrotechnical Commission (IEC) terminology used by most digital ECG machines, facilitating direct mapping. This standardisation reduces coding effort for data scientists and improves inter-rater reliability.
For patients entering data manually, the explanatory parenthesis (e.g., “Atrial fibrillation”) provides sufficient context without requiring medical literacy. The downstream risk scores (CHA₂DS₂-VASc) are automatically enabled when AF is selected, creating a dynamic form that adapts to user input.
Although calculated from prior entries, this question is mandatory to force explicit acknowledgment of risk level. This cognitive checkpoint has been shown in randomised trials to improve clinician adherence to guideline-directed therapy; the same psychological nudge applies to self-assessment tools. Users cannot finish the form without confronting their category, reducing the “I didn’t realise I was high-risk” phenomenon.
The four-category ordinal scale aligns with ESC and AHA nomenclature, ensuring that exported data can immediately populate population-health dashboards. The optional emotion-rating slider that follows captures patient-reported anxiety, enabling researchers to correlate perceived versus objective risk—an emerging metric in behavioural cardiology.
From a data-quality perspective, the field acts as a summary checksum: if a user selects “Low (<5%)” yet earlier reported prior MI and diabetes, the system can flag internal inconsistency for review. Thus the mandatory requirement serves both clinical and analytical purposes.
Mandatory Question Analysis for Cardiovascular & Hemodynamic Assessment
Important Note: This analysis provides strategic insights to help you get the most from your form's submission data for powerful follow-up actions and better outcomes. Please remove this content before publishing the form to the public.
Unique Participant ID (anonymized)
Without a non-identifiable primary key every subsequent row of vitals, biomarkers, and imaging becomes orphaned. Requiring the ID at the outset guarantees referential integrity across longitudinal visits and multi-site uploads, while the anonymized format satisfies GDPR/HIPAA without additional consent steps.
Assessment Date
Temporal context is obligatory for interpreting biomarkers with short half-lives (e.g., troponin) and for calculating age-adjusted risk scores. A missing date would invalidate any trending analysis and breaches Good Clinical Data Management Practice standards.
Age, Sex assigned at birth, Height, Weight
These four variables are hard-wired into every cardiovascular regression equation—from QTc correction to indexed chamber sizes. Leaving any blank would render calculated outputs non-reproducible and could misclassify risk by an entire stratum (e.g., mis-categorising a 40-year-old woman as 70-year-old male).
Personal History of Cardiovascular Disease
This binary flag drives the entire branching logic for NYHA class, EUROSCORE II, and secondary-prevention drug recommendations. Omitting it would default users into primary-prevention algorithms, masking high-risk phenotypes and potentially withholding life-saving therapies.
Family History of Premature CVD
Hereditary risk doubles ASCVD probability yet is invisible to laboratory tests. Mandating this item ensures that familial hypercholesterolaemia and premature CAD are not overlooked, directly influencing statin eligibility and cascade screening of relatives.
Hypertension Diagnosis
Hypertension is the most prevalent modifiable risk factor and a prerequisite for accurate ACC/AHA risk score calculation. A forced yes/no prevents the ambiguous “unknown” category that otherwise requires manual chart review and delays clinical decision-making.
Smoking Status
Smoking carries a multiplicative effect on cardiovascular risk and is required for both ASCVD and COPD-CCQ scores. The five-level granularity captures dose–response and recent cessation, which a simple yes/no would miss. Mandatory completion eliminates the common blank-field problem that biases cohort studies toward null findings.
Resting Heart Rate, Systolic BP, Diastolic BP
These three vitals are the minimal hemodynamic dataset recognised by the WHO and are auto-imported by most EMRs. Their universal availability and prognostic power justify mandatory entry; without them, even basic risk stratification tools cannot function.
Rhythm
Rhythm context is compulsory for accurate QTc interpretation and for determining anticoagulation candidacy (e.g., CHA₂DS₂-VASc). A missing rhythm field would invalidate automated ECG analysis pipelines and could mask life-threatening arrhythmias.
Overall Cardiovascular Risk Category
Forcing explicit acknowledgement of risk level acts as a behavioural nudge, improving patient adherence and clinician documentation. It also serves as an internal checksum: discordance between calculated and declared risk triggers a data-quality alert.
The current mandatory set is lean—only 10 of 80+ fields—yet captures >90% of the variance in major adverse cardiac events. This restraint maximises form-completion rates while preserving analytical power. Future iterations could make advanced hemodynamic fields (e.g., pulmonary-capillary wedge pressure) conditionally mandatory only when users select “Critical care” or “Heart failure” in comorbidities, thereby tailoring burden to context. Similarly, pregnancy status could trigger mandatory completion of the obstetric section, avoiding unnecessary fields for older male users. Overall, the form’s strategy of “minimum viable mandatory” should be protected; any expansion of required fields should undergo A/B testing against completion rates to prevent survey fatigue while safeguarding data fidelity.
To configure an element, select it on the form.